Autophagy in the fight against tuberculosis

DNA and Cell Biology

Volumn 34, Issue 4, 2015, Pages 228-242

  Bento, Carla F ^a   Empadinhas, Nuno ^b,c   Mendes, Vítor ^b,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; AUTOPHAGY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ANIMAL; DRUG DESIGN; IMMUNOLOGY; MICROBIOLOGY; TUBERCULOSIS, PULMONARY;

BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; AUTOPHAGY; DRUG DESIGN; HUMANS; IMMUNITY, INNATE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84926624385     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2745     Document Type: Article

References (129)

1. Abdallah, A.M., Gey van Pittius, N.C., Champion, P.A., Cox, J., Luirink, J., Vandenbroucke-Grauls, C.M., et al. (2007). Type VII secretion-mycobacteria show the way. Nat Rev Microbiol 5, 883-891.
2. Bach, H., Papavinasasundaram, K.G., Wong, D., Hmama, Z., and Av-Gay, Y. (2008). Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 3, 316-322.
3. Bahari, G., Hashemi, M., Taheri, M., Naderi, M., Eskandari-Nasab, E., and Atabaki, M. (2012). Association of IRGM polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast Iran. Sci World J 2012, 950801.
4. Balgi, A.D., Fonseca, B.D., Donohue, E., Tsang, T.C., Lajoie, P., Proud, C.G., et al. (2009). Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 4, e7124.
5. Ben-Ali, M., Barbouche, M.R., Bousnina, S., Chabbou, A., and Dellagi, K. (2004). Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 11, 625-626.
6. Bento, C.F., Puri, C., Moreau, K., and Rubinsztein, D.C. (2013). The role of membrane-trafficking small GTPases in the regulation of autophagy. J Cell Sci 126, 1059-1069.
7. Bowdish, D.M., Sakamoto, K., Kim, M.J., Kroos, M., Mukhopadhyay, S., Leifer, C.A., et al. (2009). MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5, e1000474.
8. Bradfute, S.B., Castillo, E.F., Arko-Mensah, J., Chauhan, S., Jiang, S., Mandell, M., et al. (2013). Autophagy as an immune effector against tuberculosis. Curr Opin Microbiol 16, 355-365.
9. Briken, V., Porcelli, S.A., Besra, G.S., and Kremer, L. (2004). Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 53, 391-403.
10. Campbell, G.R., and Spector, S.A. (2012). Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog 8, e1002689.
11. Castillo, E.F., Dekonenko, A., Arko-Mensah, J., Mandell, M.A., Dupont, N., Jiang, S., et al. (2012). Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc Natl Acad Sci USA 109, E3168-E3176.
12. Chan, J., Xing, Y., Magliozzo, R.S., and Bloom, B.R. (1992). Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175, 1111-1122.
13. Che, N., Li, S., Gao, T., Zhang, Z., Han, Y., Zhang, X., et al. (2010). Identification of a novel IRGM promoter single nucleotide polymorphism associated with tuberculosis. Clin Chim Acta 411, 1645-1649.
14. Colditz, G.A., Berkey, C.S., Mosteller, F., Brewer, T.F., Wilson, M.E., Burdick, E., et al. (1995). The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96, 29-35.
15. Collins, C.A., De Maziere, A., van Dijk, S., Carlsson, F., Klumperman, J., and Brown, E.J. (2009). Atg5-independent sequestration of ubiquitinated mycobacteria. PLoS Pathog 5, e1000430.
16. Cooper, A.M. (2009). Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27, 393-422.
17. Court, N., Vasseur, V., Vacher, R., Fremond, C., Shebzukhov, Y., Yeremeev, V.V., et al. (2010). Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J Immunol 184, 7057-7070.
18. Crisan, T.O., Plantinga, T.S., van de Veerdonk, F.L., Farcas, M.F., Stoffels, M., Kullberg, B.J., et al. (2011). Inflammasome-independent modulation of cytokine response by autophagy in human cells. PLoS One 6, e18666.
19. Davis, J.M., and Ramakrishnan, L. (2009). The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49.
20. De Carvalho, L.P., Lin, G., Jiang, X., and Nathan, C. (2009). Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance. J Med Chem 52, 5789-5792.
21. Delgado, M.A., Elmaoued, R.A., Davis, A.S., Kyei, G., and Deretic, V. (2008). Toll-like receptors control autophagy. EMBO J 27, 1110-1121.
22. Drennan, M.B., Nicolle, D., Quesniaux, V.J., Jacobs, M., Allie, N., Mpagi, J., et al. (2004). Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 164, 49-57.
23. Ehlers, S. (2010). DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. Eur J Cell Biol 89, 95-101.
24. Ernst, J.D. (2012). The immunological life cycle of tuberculosis. Nat Rev Immunol 12, 581-591.
25. Etokebe, G.E., Skjeldal, F., Nilsen, N., Rodionov, D., Knezevic, J., Bulat-Kardum, L., et al. (2010). Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand J Immunol 71, 369-381.
26. Fabri, M., Stenger, S., Shin, D.M., Yuk, J.M., Liu, P.T., Realegeno, S., et al. (2011). Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 3, 104ra102.
27. Fine, P.E. (1995). Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345.
28. Floto, R.A., Sarkar, S., Perlstein, E.O., Kampmann, B., Schreiber, S.L., and Rubinsztein, D.C. (2007). Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 3, 620-622.
29. Forsythe, P., Inman, M.D., and Bienenstock, J. (2007). Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 175, 561-569.
30. Fox, L.M., and Saravolatz, L.D. (2005). Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 40, 1173-1180.
31. Fratti, R.A., Chua, J., Vergne, I., and Deretic, V. (2003). Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci USA 100, 5437-5442.
32. Geisler, S., Holmstrom, K.M., Skujat, D., Fiesel, F.C., Rothfuss, O.C., Kahle, P.J., et al. (2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12, 119-131.
33. Ghadimi, D., de Vrese, M., Heller, K.J., and Schrezenmeir, J. (2010). Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagypromoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen. Int Immunopharmacol 10, 694-706.
34. Gomes, L.C., and Dikic, I. (2014). Autophagy in antimicrobial immunity. Mol Cell 54, 224-233.
35. Greenstein, R.J. (2003). Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 3, 507-514.
36. Gupta, A., Pant, G., Mitra, K., Madan, J., Chourasia, M.K., and Misra, A. (2014). Inhalable particles containing rapamycin for induction of autophagy in macrophages infected with Mycobacterium tuberculosis. Mol Pharm 11, 1201-1207.
37. Gutierrez, M.G., Master, S.S., Singh, S.B., Taylor, G.A., Colombo, M.I., and Deretic, V. (2004). Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753-766.
38. Harboe, M., Oettinger, T., Wiker, H.G., Rosenkrands, I., and Andersen, P. (1996). Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64, 16-22.
39. Harris, J. (2011). Autophagy and cytokines. Cytokine 56, 140-144.
40. Harris, J., De Haro, S.A., Master, S.S., Keane, J., Roberts, E.A., Delgado, M., et al. (2007). T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27, 505-517.
41. Harris, J., Hartman, M., Roche, C., Zeng, S.G., O'Shea, A., Sharp, F.A., et al. (2011). Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 286, 9587-9597.
42. Harris, J., Hope, J.C., and Keane, J. (2008). Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. J Infect Dis 198, 1842-1850.
43. Horwitz, M.A., Harth, G., Dillon, B.J., and Maslesa-Galic, S. (2006). A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG. Vaccine 24, 1593-1600.
44. Huang, J., and Brumell, J.H. (2014). Bacteria-autophagy interplay: a battle for survival. Nat Rev Microbiol 12, 101-114.
45. Intemann, C.D., Thye, T., Niemann, S., Browne, E.N., Amanua Chinbuah, M., Enimil, A., et al. (2009). Autophagy gene variant IRGM-261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog 5, e1000577.
46. Ishikawa, E., Ishikawa, T., Morita, Y.S., Toyonaga, K., Yamada, H., Takeuchi, O., et al. (2009). Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206, 2879-2888.
47. Jagannath, C., Lindsey, D.R., Dhandayuthapani, S., Xu, Y., Hunter, R.L., Jr., and Eissa, N.T. (2009). Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15, 267-276.
48. Jo, E.K. (2013). Autophagy as an innate defense against mycobacteria. Pathog Dis 67, 108-118.
49. Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., et al. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.
50. Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S.E., Fondaneche, M.C., Dupuis, S., et al. (1999). A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 21, 370-378.
51. Juarez, E., Carranza, C., Hernandez-Sanchez, F., Leon-Contreras, J.C., Hernandez-Pando, R., Escobedo, D., et al. (2012). NOD2 enhances the innate response of alveolar macrophages to Mycobacterium tuberculosis in humans. Eur J Immunol 42, 880-889.
52. Kearns, M.D., Alvarez, J.A., Seidel, N., and Tangpricha, V. (2014). Impact of vitamin D on infectious disease: a systematic review of controlled trials. Am J Med Sci [Epub ahead of print]; DOI: 10.1097/MAJ.0000000000000360.
53. Kim, J.J., Lee, H.M., Shin, D.M., Kim, W., Yuk, J.M., Jin, H.S., et al. (2012a). Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe 11, 457-468.
54. Kim, K.H., An, D.R., Song, J., Yoon, J.Y., Kim, H.S., Yoon, H.J., et al. (2012b). Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci USA 109, 7729-7734.
55. King, K.Y., Lew, J.D., Ha, N.P., Lin, J.S., Ma, X., Graviss, E.A., et al. (2011). Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS One 6, e16317.
56. Kleinnijenhuis, J., Oosting, M., Joosten, L.A., Netea, M.G., and Van Crevel, R. (2011). Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol 2011, 405310.
57. Kumar, D., Nath, L., Kamal, M.A., Varshney, A., Jain, A., Singh, S., et al. (2010). Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140, 731-743.
58. Kwak, B., Mulhaupt, F., Myit, S., and Mach, F. (2000). Statins as a newly recognized type of immunomodulator. Nat Med 6, 1399-1402.
59. Lam, K.K., Zheng, X., Forestieri, R., Balgi, A.D., Nodwell, M., Vollett, S., et al. (2012). Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. PLoS Pathog 8, e1002691.
60. Lang, R. (2013). Recognition of the mycobacterial cord factor by Mincle: relevance for granuloma formation and resistance to tuberculosis. Front Immunol 4, 5.
61. Lee, J., Repasy, T., Papavinasasundaram, K., Sassetti, C., and Kornfeld, H. (2011). Mycobacterium tuberculosis induces an atypical cell death mode to escape from infected macrophages. PLoS One 6, e18367.
62. Liao, J.K., and Laufs, U. (2005). Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45, 89-118.
63. Lin, P.L., Ford, C.B., Coleman, M.T., Myers, A.J., Gawande, R., Ioerger, T., et al. (2014). Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 20, 75-79.
64. Lobato, L.S., Rosa, P.S., Ferreira Jda, S., Neumann Ada, S., da Silva, M.G., do Nascimento, D.C., et al. (2014). Statins increase rifampin mycobactericidal effect. Antimicrob Agents Chemother 58, 5766-5774.
65. MacMicking, J.D., Taylor, G.A., and McKinney, J.D. (2003). Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302, 654-659.
66. Manzanillo, P.S., Ayres, J.S., Watson, R.O., Collins, A.C., Souza, G., Rae, C.S., et al. (2013). The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 501, 512-516.
67. Martineau, A.R., Timms, P.M., Bothamley, G.H., Hanifa, Y., Islam, K., Claxton, A.P., et al. (2011). High-dose vitamin D (3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377, 242-250.
68. Meerak, J., Wanichwecharungruang, S.P., and Palaga, T. (2013). Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. Vaccine 31, 784-790.
69. Mira, M.T., Alcais, A., Nguyen, V.T., Moraes, M.O., Di Flumeri, C., Vu, H.T., et al. (2004). Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427, 636-640.
70. Mizushima, N. (2011). Autophagy in protein and organelle turnover. Cold Spring Harb Symp Quant Biol 76, 397-402.
71. Nagahara, Y., Takeyoshi, M., Sakemoto, S., Shiina, I., Nakata, K., Fujimori, K., et al. (2013). Novel tamoxifen derivative Ridaifen-B induces Bcl-2 independent autophagy without estrogen receptor involvement. Biochem Biophys Res Commun 435, 657-663.
72. Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C., et al. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12, 222-230.
73. Ni Cheallaigh, C., Keane, J., Lavelle, E.C., Hope, J.C., and Harris, J. (2011). Autophagy in the immune response to tuberculosis: clinical perspectives. Clin Exp Immunol 164, 291-300.
74. Nobre, A., Alarico, S., Maranha, A., Mendes, V., and Empadinhas, N. (2014). The molecular biology of mycobacterial trehalose in the quest for advanced tuberculosis therapies. Microbiology 160, 1547-1570.
75. Ogus, A.C., Yoldas, B., Ozdemir, T., Uguz, A., Olcen, S., Keser, I., et al. (2004). The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23, 219-223.
76. Parihar, S.P., Guler, R., Khutlang, R., Lang, D.M., Hurdayal, R., Mhlanga, M.M., et al. (2014). Statin therapy reduces the Mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. J Infect Dis 209, 754-763.
77. Philips, J.A. (2008). Mycobacterial manipulation of vacuolar sorting. Cell Microbiol 10, 2408-2415.
78. Philips, J.A., and Ernst, J.D. (2012). Tuberculosis pathogenesis and immunity. Annu Rev Pathol 7, 353-384.
79. Pilli, M., Arko-Mensah, J., Ponpuak, M., Roberts, E., Master, S., Mandell, M.A., et al. (2012). TBK-1 promotes autophagymediated antimicrobial defense by controlling autophagosome maturation. Immunity 37, 223-234.
80. Ralph, A.P., Lucas, R.M., and Norval, M. (2013). Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect Dis 13, 77-88.
81. Ravikumar, B., Futter, M., Jahreiss, L., Korolchuk, V.I., Lichtenberg, M., Luo, S., et al. (2009). Mammalian macroautophagy at a glance. J Cell Sci 122, 1707-1711.
82. Ray, K.K., Seshasai, S.R., Erqou, S., Sever, P., Jukema, J.W., Ford, I., et al. (2010). Statins and all-cause mortality in highrisk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65, 229 participants. Arch Intern Med 170, 1024-1031.
83. Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M.H., Hegyi, K., et al. (2011). Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 121, 3554-3563.
84. Rivas-Santiago, B., and Cervantes-Villagrana, A.R. (2014). Novel approaches to tuberculosis prevention: DNA vaccines. Scand J Infect Dis 46, 161-168.
85. Rossignol, J.F., Kabil, S.M., el-Gohary, Y., and Younis, A.M. (2006). Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol 4, 320-324.
86. Rubinsztein, D.C., Gestwicki, J.E., Murphy, L.O., and Klionsky, D.J. (2007). Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6, 304-312.
87. Saitoh, T., Fujita, N., Jang, M.H., Uematsu, S., Yang, B.G., Satoh, T., et al. (2008). Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264-268.
88. Salahuddin, N., Ali, F., Hasan, Z., Rao, N., Aqeel, M., and Mahmood, F. (2013). Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'. BMC Infect Dis 13, 22.
89. Sanjuan, M.A., Dillon, C.P., Tait, S.W., Moshiach, S., Dorsey, F., Connell, S., et al. (2007). Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450, 1253-1257.
90. Saraav, I., Singh, S., and Sharma, S. (2014). Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response or immune evasion? Immunol Cell Biol 92, 741-746.
91. Sarkar, S. (2013). Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. Biochem Soc Trans 41, 1103-1130.
92. Sarkar, S., Floto, R.A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., et al. (2005). Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170, 1101-1111.
93. Sarkar, S., Perlstein, E.O., Imarisio, S., Pineau, S., Cordenier, A., Maglathlin, R.L., et al. (2007). Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 3, 331-338.
94. Schafer, G., Jacobs, M., Wilkinson, R.J., and Brown, G.D. (2009). Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes. J Innate Immun 1, 231-243.
95. Seto, S., Tsujimura, K., and Koide, Y. (2012). Coronin-1a inhibits autophagosome formation around Mycobacterium tuberculosis-containing phagosomes and assists mycobacterial survival in macrophages. Cell Microbiol 14, 710-727.
96. Shah, S., Bohsali, A., Ahlbrand, S.E., Srinivasan, L., Rathinam, V.A., Vogel, S.N., et al. (2013). Cutting edge: Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFNbeta and AIM2 inflammasome-dependent IL-1beta production via its ESX-1 secretion system. J Immunol 191, 3514-3518.
97. Shi, C.S., and Kehrl, J.H. (2008). MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 283, 33175-33182.
98. Shin, D.M., Jeon, B.Y., Lee, H.M., Jin, H.S., Yuk, J.M., Song, C.H., et al. (2010a). Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redoxdependent signaling. PLoS Pathog 6, e1001230.
99. Shin, D.M., Yuk, J.M., Lee, H.M., Lee, S.H., Son, J.W., Harding, C.V., et al. (2010b). Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol 12, 1648-1665.
100. Shui, W., Petzold, C.J., Redding, A., Liu, J., Pitcher, A., Sheu, L., et al. (2011). Organelle membrane proteomics reveals differential influence of mycobacterial lipoglycans on macrophage phagosome maturation and autophagosome accumulation. J Proteome Res 10, 339-348.
101. Singh, S.B., Davis, A.S., Taylor, G.A., and Deretic, V. (2006). Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438-1441.
102. Skerry, C., Pinn, M.L., Bruiners, N., Pine, R., Gennaro, M.L., and Karakousis, P.C. (2014). Simvastatin increases the in vivo activity of the first-line tuberculosis regimen. J Antimicrob Chemother 69, 2453-2457.
103. Songane, M., Kleinnijenhuis, J., Alisjahbana, B., Sahiratmadja, E., Parwati, I., Oosting, M. et al. (2012). Polymorphisms in autophagy genes and susceptibility to tuberculosis. Plos one 7, e41618.
104. Stanley, S.A., Barczak, A.K., Silvis, M.R., Luo, S.S., Sogi, K., Vokes, M., et al. (2014). Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog 10, e1003946.
105. Suarez-Mendez, R., Garcia-Garcia, I., Fernandez-Olivera, N., Valdes-Quintana, M., Milanes-Virelles, M.T., Carbonell, D., et al. (2004). Adjuvant interferon gamma in patients with drug-resistant pulmonary tuberculosis: a pilot study. BMC Infect Dis 4, 44.
106. Sun, H., Wang, Y., Ma, X., Pei, F., Sun, H., Zhang, Y., Yu, B. (2007). A method of oligochip for single nucleotide polymorphism genotyping in the promoter region of the interleukin-1 beta gene and its clinical application. Oligonucleotides 17, 336-344.
107. Sundaramurthy, V., Barsacchi, R., Samusik, N., Marsico, G., Gilleron, J., Kalaidzidis, I., et al. (2013). Integration of chemical and RNAi multiparametric profiles identifies triggers of intracellular mycobacterial killing. Cell Host Microbe 13, 129-142.
108. Tleyjeh, I.M., Kashour, T., Hakim, F.A., Zimmerman, V.A., Erwin, P.J., Sutton, A.J., et al. (2009). Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 169, 1658-1667.
109. Tobin, D.M., and Ramakrishnan, L. (2008). Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell Microbiol 10, 1027-1039.
110. van der Wel, N., Hava, D., Houben, D., Fluitsma, D., van Zon, M., Pierson, J., et al. (2007). M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129, 1287-1298.
111. Vergne, I., Chua, J., Lee, H.H., Lucas, M., Belisle, J., and Deretic, V. (2005). Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci USA 102, 4033-4038.
112. Vergne, I., Fratti, R.A., Hill, P.J., Chua, J., Belisle, J., and Deretic, V. (2004). Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol Biol Cell 15, 751-760.
113. Via, L.E., Deretic, D., Ulmer, R.J., Hibler, N.S., Huber, L.A., and Deretic, V. (1997). Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J Biol Chem 272, 13326-13331.
114. Villarreal, D.O., Walters, J., Laddy, D.J., Yan, J., and Weiner, D.B. (2014). Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG. Hum Vaccin Immunother 10, 2188-2198.
115. Watson, R.O., Manzanillo, P.S., and Cox, J.S. (2012). Extracellular, M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150, 803-815.
116. Wei, J., Dahl, J.L., Moulder, J.W., Roberts, E.A., O'Gaora, P., Young, D.B., et al. (2000). Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages. J Bacteriol 182, 377-384.
117. Wei, Y.M., Li, X., Xu, M., Abais, J.M., Chen, Y., Riebling, C.R., et al. (2013). Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 31, 925-937.
118. Wejse, C., Gomes, V.F., Rabna, P., Gustafson, P., Aaby, P., Lisse, I.M., et al. (2009). Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebocontrolled trial. Am J Respir Crit Care Med 179, 843-850.
119. Wellcome Trust Case Control Consortium. (2007). Genomewide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447, 661-678.
120. Wienecke, R., Fackler, I., Linsenmaier, U., Mayer, K., Licht, T., and Kretzler, M. (2006). Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am J Kidney Dis 48, e27-e29.
121. Wilkinson, R.J., Llewelyn, M., Toossi, Z., Patel, P., Pasvol, G., Lalvani, A., et al. (2000). Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355, 618-621.
122. Xiong, Y., Song, C., Snyder, G.A., Sundberg, E.J., and Medvedev, A.E. (2012). R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88. J Biol Chem 287, 38327-38337.
123. Xu, Y., Jagannath, C., Liu, X.D., Sharafkhaneh, A., Kolodziejska, K.E., and Eissa, N.T. (2007). Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27, 135-144.
124. Yang, C.S., Kim, J.J., Lee, H.M., Jin, H.S., Lee, S.H., Park, J.H., et al. (2014). The AMPK-PPARGC1A pathway is required for antimicrobial host defense through activation of autophagy. Autophagy 10, 785-802.
125. Youle, R.J., and Narendra, D.P. (2011). Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12, 9-14.
126. Yu, X., Li, C., Hong, W., Pan, W., and Xie, J. (2013). Autophagy during Mycobacterium tuberculosis infection and implications for future tuberculosis medications. Cell Signal 25, 1272-1278.
127. Yuk, J.M., Shin, D.M., Lee, H.M., Yang, C.S., Jin, H.S., Kim, K.K., et al. (2009). Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6, 231-243.
128. Zarate-Blades, C.R., Rodrigues, R.F., Souza, P.R., Rios, W.M., Soares, L.S., Rosada, R.S., et al. (2013). Evaluation of the overall IFN-gamma and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis. Hum Vaccin Immunother 9, 1093-1103.
129. Zhou, R., Yazdi, A.S., Menu, P., and Tschopp, J. (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225.